Detection of RET fusion in late-line treatment of NSCLC followed by long-term disease control with selpercatinib

Miriam Šuranová, Ondřej Bílek, Aleš Neumann, Jitka Berkovcová, Tomáš Kazda, Igor Kiss

Open source

DOI
10.48095/ccko2026368
Published
2026-10-15
Container
Klinicka onkologie
Publisher
Care Comm
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.48095/ccko2026368,
  title = {Detection of RET fusion in late-line treatment of NSCLC followed by long-term disease control with selpercatinib},
  author = {Miriam Šuranová and Ondřej Bílek and Aleš Neumann and Jitka Berkovcová and Tomáš Kazda and Igor Kiss},
  year = {2026},
  journal = {Klinicka onkologie},
  doi = {10.48095/ccko2026368},
  url = {https://doi.org/10.48095/ccko2026368}
}

RIS

TY  - JOUR
TI  - Detection of RET fusion in late-line treatment of NSCLC followed by long-term disease control with selpercatinib
AU  - Miriam Šuranová
AU  - Ondřej Bílek
AU  - Aleš Neumann
AU  - Jitka Berkovcová
AU  - Tomáš Kazda
AU  - Igor Kiss
PY  - 2026
JO  - Klinicka onkologie
DO  - 10.48095/ccko2026368
UR  - https://doi.org/10.48095/ccko2026368
ER  - 

APA

Šuranová, M., Bílek, O., Neumann, A., Berkovcová, J., Kazda, T., & Kiss, I. (2026). Detection of RET fusion in late-line treatment of NSCLC followed by long-term disease control with selpercatinib. Klinicka onkologie. https://doi.org/10.48095/ccko2026368

Source records